Paper40891745
Structural insights into Arylidenehydrazinyl Benzenesulfonamides as potent mycobacterial carbonic anhydrase inhibitors.
Kumar P and 11 others. Future Med Chem, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Structural insights into Arylidenehydrazinyl Benzenesulfonamides as potent mycobacterial carbonic anhydrase inhibitors. Papers, record 40891745. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40891745
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Structural insights into Arylidenehydrazinyl Benzenesulfonamides as potent mycobacterial carbonic anhydrase inhibitors.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carbonic Anhydrase Inhibitors | Major topic |
| Mycobacterium tuberculosis | Major topic |
| Sulfonamides | Major topic |
| Carbonic Anhydrases | Major topic |
| Antitubercular Agents | Major topic |
| Humans | |
| Microbial Sensitivity Tests | |
| Molecular Docking Simulation | |
| Structure-Activity Relationship | |
| Molecular Structure | |
| Molecular Dynamics Simulation | |
| Benzenesulfonamides |
Source PubMed
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12657046 | Genes required for mycobacterial growth defined by high density mutagenesis. | Mol Microbiol | 2003 | https://conductscience.org/library/papers/12657046 | PubMed |
| 2 | 8795459 | Membrane carbonic anhydrase (IV) and ciliary epithelium. Carbonic anhydrase activity is present in the basolateral membranes of the non-pigmented ciliary epithelium of rabbit eyes. | Exp Eye Res | 1996 | https://conductscience.org/library/papers/8795459 | PubMed |
| 3 | 15028762 | Carbonic anhydrase isoform VII acts as a molecular switch in the development of synchronous gamma-frequency firing of hippocampal CA1 pyramidal cells. | J Neurosci | 2004 | https://conductscience.org/library/papers/15028762 | PubMed |
| 4 | 14600151 | Characterization of CA XIII, a novel member of the carbonic anhydrase isozyme family. | J Biol Chem | 2004 | https://conductscience.org/library/papers/14600151 | PubMed |
| 5 | 10649985 | Carbonic anhydrase inhibitors: synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes. | J Med Chem | 2000 | https://conductscience.org/library/papers/10649985 | PubMed |
| 6 | 19211803 | Pathogenesis of retinitis pigmentosa associated with apoptosis-inducing mutations in carbonic anhydrase IV. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19211803 | PubMed |
| 7 | 40613379 | Exploration of pyrazole-based pyridine-4-carbohydrazide derivatives as drug-resistant Mtb agents: design, synthesis, biological evaluation, and in-silico studies. | Future Med Chem | 2025 | https://conductscience.org/library/papers/40613379 | PubMed |
| 8 | 18167490 | Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. | Nat Rev Drug Discov | 2008 | https://conductscience.org/library/papers/18167490 | PubMed |
| 9 | 23265903 | Inhibition of the β-carbonic anhydrases from Mycobacterium tuberculosis with C-cinnamoyl glycosides: identification of the first inhibitor with anti-mycobacterial activity. | Bioorg Med Chem Lett | 2013 | https://conductscience.org/library/papers/23265903 | PubMed |
| 10 | 40817577 | Exploration of New Dihydroindazole Derivatives as Promising Anti-TB Agents: Design, Synthesis, In Silico, and Biological Evaluation. | Arch Pharm (Weinheim) | 2025 | https://conductscience.org/library/papers/40817577 | PubMed |
| 11 | 37241761 | Inhibition Studies on Human and Mycobacterial Carbonic Anhydrases with N-((4-Sulfamoylphenyl)carbamothioyl) Amides. | Molecules | 2023 | https://conductscience.org/library/papers/37241761 | PubMed |
| 12 | 39222997 | Mycobacterial β-carbonic anhydrases: Molecular biology, role in the pathogenesis of tuberculosis and inhibition studies. | Enzymes | 2024 | https://conductscience.org/library/papers/39222997 | PubMed |
| 13 | 12676895 | Expression of cell surface transmembrane carbonic anhydrase genes CA9 and CA12 in the human eye: overexpression of CA12 (CAXII) in glaucoma. | J Med Genet | 2003 | https://conductscience.org/library/papers/12676895 | PubMed |
| 14 | 38473830 | Benzothiadiazinone-1,1-Dioxide Carbonic Anhydrase Inhibitors Suppress the Growth of Drug-Resistant Mycobacterium tuberculosis Strains. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38473830 | PubMed |
| 15 | 31627429 | Mycobacterium tuberculosis β-Carbonic Anhydrases: Novel Targets for Developing Antituberculosis Drugs. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31627429 | PubMed |
| 16 | 18274517 | Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. | Nat Protoc | 2008 | https://conductscience.org/library/papers/18274517 | PubMed |
| 17 | 17482815 | Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors. | Bioorg Med Chem Lett | 2007 | https://conductscience.org/library/papers/17482815 | PubMed |
| 18 | 39191032 | Recent advances and challenges of revolutionizing drug-resistant tuberculosis treatment. | Eur J Med Chem | 2024 | https://conductscience.org/library/papers/39191032 | PubMed |
| 19 | 24156740 | Sulfonamides incorporating fluorine and 1,3,5-triazine moieties are effective inhibitors of three β-class carbonic anhydrases from Mycobacterium tuberculosis. | J Enzyme Inhib Med Chem | 2014 | https://conductscience.org/library/papers/24156740 | PubMed |
| 20 | 19703035 | Which carbonic anhydrases are targeted by the antiepileptic sulfonamides and sulfamates? | Chem Biol Drug Des | 2009 | https://conductscience.org/library/papers/19703035 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42760852 | Design, Synthesis, Antimycobacterial Evaluation, and In Silico Investigation of Benzisothiazole-Based Hydrazide Derivatives as Potential Anti-Tuberculosis Agents. | Chem Biol Drug Des | 2026 | https://conductscience.org/library/papers/42760852 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CYP24A1 | 1591 | PubTator's text mining | https://conductscience.org/library/genes/1591 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40891745
GET https://conductscience.org/api/papers/v1/40891745/references?page=2